Frankfurt - Delayed Quote EUR
Denali Therapeutics Inc. (4DN.F)
12.36
-0.31
(-2.41%)
As of 8:19:29 AM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
COOK JENNIFER E Director | Sale | Jun 6, 2024 | 20,038 |
FLATLEY JAY T Director | Stock Award(Grant) | May 31, 2024 | 346,496 |
HARRIS ERIK Director | Stock Award(Grant) | May 31, 2024 | 17,052 |
HO CAROLE Officer | Sale | Jan 7, 2025 | 383,892 |
KROGNES STEVE E Director | Sale | Jan 7, 2025 | 807,554 |
SATO VICKI LEE Director | Sale | Jan 2, 2025 | 107,976 |
SCHENKEIN DAVID P Director | Sale | Nov 11, 2024 | 66,684 |
SCHUTH ALEXANDER O Chief Operating Officer | Sale | Jan 7, 2025 | 768,057 |
THORNBERRY NANCY A. Director | Stock Award(Grant) | May 31, 2024 | 18,680 |
WATTS RYAN J Chief Executive Officer | Sale | Jan 7, 2025 | 2,455,680 |
Related Tickers
BH3.F PTC Therapeutics, Inc.
41.00
0.00%
XP0.F Xenon Pharmaceuticals Inc.
26.40
0.00%
WXXWY WuXi Biologics (Cayman) Inc.
6.01
+0.17%
VIGL Vigil Neuroscience, Inc.
2.3691
-0.04%
COCP Cocrystal Pharma, Inc.
1.4450
-5.86%
2269.HK WuXi Biologics (Cayman) Inc.
23.850
+0.21%
CRNX Crinetics Pharmaceuticals, Inc.
31.01
-0.91%
HOWL Werewolf Therapeutics, Inc.
1.0950
+10.59%
FOLD Amicus Therapeutics, Inc.
5.95
+1.11%
ANNX Annexon, Inc.
1.7550
-0.28%